Authors
Kristin M Holland, Christopher Jones, Alana M Vivolo-Kantor, Nimi Idaikkadar, Marissa Zwald, Brooke Hoots, Ellen Yard, Ashley D’Inverno, Elizabeth Swedo, May S Chen, Emiko Petrosky, Amy Board, Pedro Martinez, Deborah M Stone, Royal Law, Michael A Coletta, Jennifer Adjemian, Craig Thomas, Richard W Puddy, Georgina Peacock, Nicole F Dowling, Debra Houry
Publication date
2021/4/1
Journal
JAMA psychiatry
Volume
78
Issue
4
Pages
372-379
Publisher
American Medical Association
Description
Importance
The coronavirus disease 2019 (COVID-19) pandemic, associated mitigation measures, and social and economic impacts may affect mental health, suicidal behavior, substance use, and violence.
Objective
To examine changes in US emergency department (ED) visits for mental health conditions (MHCs), suicide attempts (SAs), overdose (OD), and violence outcomes during the COVID-19 pandemic.
Design, Setting, and Participants
This cross-sectional study used data from the Centers for Disease Control and Prevention’s National Syndromic Surveillance Program to examine national changes in ED visits for MHCs, SAs, ODs, and violence from December 30, 2018, to October 10, 2020 (before and during the COVID-19 pandemic). The National Syndromic Surveillance Program captures approximately 70% of US ED visits from more than 3500 EDs that cover 48 states and Washington, DC.
Main Outcomes …
Scholar articles
KM Holland, C Jones, AM Vivolo-Kantor, N Idaikkadar… - JAMA psychiatry, 2021